Searching News Database: IPLEX
HSMN NewsFeed - 12 Feb 2009
Insmed Sells Follow-on Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million
Insmed Sells Follow-on Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million
HSMN NewsFeed - 10 Jan 2007
Italian Ministry of Health Requests IPLEX(TM) for Treatment of ALS (Lou Gehrig's Disease)
Italian Ministry of Health Requests IPLEX(TM) for Treatment of ALS (Lou Gehrig's Disease)
HSMN NewsFeed - 6 Dec 2006
Jury Finds Insmed Infringed Patents Owned By Genentech And Exclusively Licensed to Tercica
Jury Finds Insmed Infringed Patents Owned By Genentech And Exclusively Licensed to Tercica
Additional items found! 9
Members Archive contains
9 additional stories matching:
IPLEX
(Password required)
IPLEX
(Password required)